Denali Therapeutics Inc (NASDAQ:DNLI)

28.25
BATS BZX Real-Time Price
As of 11:14am ET
 -1.08 / -3.68%
Today’s Change
20.24
Today|||52-Week Range
79.70
-36.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.00129.2M
 
 
Depreciation And Amortization121.0K1.5M3.1M7.4M
 
 
 
 
 
 
Operating ExpensesGross Income-121.0K-1.5M-3.1M--
 
 
 
 
General Expenses16.6M86.0M87.1M160.2M
 
 
 
 
 
Research And Development11.5M74.2M71.4M135.3M
 
 
 
 
 
Total Operating Expenses16.7M87.4M90.1M167.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.7M-87.4M-90.1M-38.5M
 
 
 
 
 
Extraordinary Charge0.000.000.00-8.1M
 
 
Interest Expense On Debt109.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.8M-86.7M-88.2M-36.2M
 
 
 
 
 
Net Income-16.8M-86.7M-88.2M-36.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS90.1M90.1M15.0M92.6M
 
 
 
 
 
Shares To Calculate EPS Diluted90.1M90.1M15.0M92.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.19-$0.96-$5.89-$0.39
 
 
 
 
 
EPS Diluted-$0.19-$0.96-$5.89-$0.39